Myriam Labopin Selected Research

Azacitidine (5 Azacytidine)

1/2020	Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation.
11/2019	Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome.
1/2016	Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myriam Labopin Research Topics

Disease

192	Leukemia 05/2024 - 04/2002
178	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 11/2002
61	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 02/2004
57	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 02/2008
17	Pathologic Complete Response 05/2024 - 11/2010
16	Neoplasms (Cancer) 03/2021 - 03/2015
10	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 02/2006
9	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2010
7	Bronchiolitis Obliterans Syndrome 11/2021 - 05/2015
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 07/2008
6	Residual Neoplasm 12/2023 - 09/2014
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2019 - 09/2014
5	Crohn Disease (Crohn's Disease) 05/2019 - 12/2015
4	Hematologic Diseases (Blood Diseases) 01/2021 - 01/2017
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2023 - 01/2018
3	Philadelphia Chromosome 01/2021 - 03/2015
3	Infections 01/2020 - 09/2015
3	Sickle Cell Anemia (Hemoglobin S Disease) 12/2019 - 01/2017
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 12/2017
2	COVID-19 01/2021 - 01/2021
2	monosomy Chromosome 7 01/2020 - 01/2018
2	Monosomy 01/2020 - 01/2018
2	Inflammation (Inflammations) 05/2019 - 01/2017
1	Bacteremia 11/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Cardiotoxicity 06/2021
1	Acute Promyelocytic Leukemia 01/2021
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hyperbilirubinemia 12/2020
1	Malnutrition (Nutritional Deficiencies) 11/2020
1	Sarcoma (Soft Tissue Sarcoma) 10/2020
1	Toxoplasmosis 01/2020
1	Bone Marrow Failure Disorders 01/2020
1	Cytopenia 01/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Bites and Stings (Sting) 01/2020
1	Multiple Sclerosis 01/2020
1	Immune System Diseases (Immune Disorders) 10/2019
1	Arthralgia (Joint Pain) 01/2019

Drug/Important Bio-Agent (IBA)

66	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 10/2013
31	Busulfan (Busulfex)FDA Link 11/2023 - 10/2013
27	fludarabineIBA 10/2023 - 04/2015
23	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2024 - 05/2015
16	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2023 - 01/2016
10	treosulfanIBA 10/2023 - 07/2017
10	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022 - 11/2008
7	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2024 - 03/2016
7	Melphalan (Alkeran)FDA LinkGeneric 11/2023 - 04/2015
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 05/2015
5	Calcineurin InhibitorsIBA 04/2024 - 03/2016
5	AntigensIBA 04/2024 - 05/2019
5	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 07/2008
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2015
5	Clofarabine (Clolar)FDA Link 08/2020 - 09/2012
4	Methotrexate (Mexate)FDA LinkGeneric 04/2024 - 12/2020
4	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 01/2018
3	Etoposide (VP 16)FDA LinkGeneric 11/2023 - 01/2018
3	defibrotideIBA 01/2023 - 01/2018
3	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 01/2016
3	SteroidsIBA 01/2017 - 04/2002
2	Core Binding Factors (Core-Binding Factor)IBA 04/2024 - 01/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2024 - 10/2020
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 12/2019
2	Gemtuzumab (Mylotarg)FDA Link 12/2020 - 01/2020
2	AntibodiesIBA 01/2020 - 02/2015
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2016 - 02/2004
1	NucleophosminIBA 01/2024
1	thymoglobulin FDA Link 12/2023
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2023
1	N-formyl-13-dihydrocarminomycin (NFD)IBA 01/2023
1	Prostaglandins FIBA 01/2023
1	Amsacrine (AMSA)IBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Core Binding Factor Alpha 2 SubunitIBA 10/2021
1	Transaminases (Aminotransferases)IBA 12/2020
1	Thymidine Monophosphate (TMP)IBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2020
1	Phenobarbital (Luminal)FDA Link 05/2019

Therapy/Procedure

179	Transplantation 05/2024 - 04/2002
128	Stem Cell Transplantation 05/2024 - 02/2003
84	Hematopoietic Stem Cell Transplantation 03/2024 - 11/2002
61	Cell Transplantation 04/2024 - 02/2015
31	Therapeutics 01/2021 - 04/2002
22	Haploidentical Transplantation 05/2024 - 04/2015
22	Drug Therapy (Chemotherapy) 03/2024 - 06/2008
16	Homologous Transplantation 04/2024 - 11/2002
11	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 04/2002
8	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 12/2022 - 03/2015
5	Autologous Transplantation 01/2023 - 01/2005
2	Drug Tapering 11/2023 - 04/2002
1	Cord Blood Stem Cell Transplantation 10/2022
1	Traction 01/2021
1	Nutritional Support (Artificial Feeding) 11/2020
1	Donor Selection 11/2019
1	Biological Therapy 05/2019